nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A comprehensive, multifaceted strategy to increase pediatric donor heart utilization
|
Hollander, Seth A. |
|
|
43 |
10 |
p. 1747-1755 |
artikel |
2 |
Application of REVEAL Lite 2 and COMPERA 2.0 risk scores to patients with pulmonary arterial hypertension switching to riociguat in the REPLACE study
|
Benza, Raymond L. |
|
|
43 |
10 |
p. 1756-1760 |
artikel |
3 |
Are the new ISHLT definitions of infection during mechanical circulatory support appropriate for ECMO?
|
Marcus, Joseph E. |
|
|
43 |
10 |
p. 1761-1762 |
artikel |
4 |
Balloon pulmonary angioplasty: Not quite the fountain of youth in chronic thromboembolic pulmonary hypertension
|
Gurevich, Sergey |
|
|
43 |
10 |
p. 1652-1653 |
artikel |
5 |
Comparison of cardiac allograft vasculopathy incidence between simultaneous multiorgan and isolated heart transplant recipients in the United States
|
Shahandeh, Negeen |
|
|
43 |
10 |
p. 1737-1746 |
artikel |
6 |
Donor plasma VEGF-A as a biomarker for myocardial injury and primary graft dysfunction after heart transplantation
|
Holmström, Emil J. |
|
|
43 |
10 |
p. 1677-1690 |
artikel |
7 |
Donor to recipient age matching in lung transplantation: A European experience
|
Pradere, P. |
|
|
43 |
10 |
p. 1716-1726 |
artikel |
8 |
Editorial Board
|
|
|
|
43 |
10 |
p. A1 |
artikel |
9 |
Effects of medical therapy and age on cardiac output changes following balloon pulmonary angioplasty: Implications for combination therapy in chronic thromboembolic pulmonary hypertension
|
Kanezawa, Misaki |
|
|
43 |
10 |
p. 1642-1651 |
artikel |
10 |
Information for Readers
|
|
|
|
43 |
10 |
p. A2 |
artikel |
11 |
International Society for Heart and Lung Transplantation Guidelines for the Evaluation and Care of Cardiac Transplant Candidates—2024
|
Peled, Yael |
|
|
43 |
10 |
p. 1529-1628.e54 |
artikel |
12 |
Of rivers, recipients and rejection: Revelations from deep immune phenotyping of lung allograft transbronchial biopsy tissue
|
Calabrese, Daniel R. |
|
|
43 |
10 |
p. 1665-1667 |
artikel |
13 |
Outcomes of lung transplantation for pleuroparenchymal fibroelastosis: A French multicentric retrospective study
|
Clermidy, H. |
|
|
43 |
10 |
p. 1727-1736 |
artikel |
14 |
Pediatric lung transplantation: A new landscape following the height of the COVID-19 pandemic
|
Avdimiretz, Nicholas |
|
|
43 |
10 |
p. 1763-1765 |
artikel |
15 |
Right ventricular phenotyping in incident patients with idiopathic pulmonary arterial hypertension
|
Ghio, Stefano |
|
|
43 |
10 |
p. 1668-1676 |
artikel |
16 |
Spectrum of chronic lung allograft dysfunction pathology in human lung transplantation
|
Renaud-Picard, Benjamin |
|
|
43 |
10 |
p. 1701-1715 |
artikel |
17 |
Table of Contents
|
|
|
|
43 |
10 |
p. A3-A5 |
artikel |
18 |
The CD8+ T cell content of transbronchial biopsies from patients with a first episode of clinically stable grade A1 cellular rejection is associated with future chronic lung allograft dysfunction
|
Beber, Samuel A. |
|
|
43 |
10 |
p. 1654-1664 |
artikel |
19 |
The evolving epidemiology of systemic sclerosis-associated pulmonary hypertension
|
Simpson, Catherine E. |
|
|
43 |
10 |
p. 1640-1641 |
artikel |
20 |
The spectrum of systemic sclerosis-associated pulmonary hypertension: Insights from the ASPIRE registry
|
Smith, Howard |
|
|
43 |
10 |
p. 1629-1639 |
artikel |
21 |
Utilization and outcomes of expanded criteria donors in adults with congenital heart disease
|
Akbar, Armaan F. |
|
|
43 |
10 |
p. 1691-1700 |
artikel |